Search
Now showing items 1-1 of 1
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
(Springer Science and Business Media LLC, 2008-04-14)
Genetic alterations in the kinase domain of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) patients are associated with sensitivity to treatment with small molecule tyrosine kinase ...